Search

Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations.

In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies.

Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models.

Publisher Correction: Epigenetic alterations of repeated relapses in patient-matched childhood ependymomas.

Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas.

Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma.

Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies.

Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies.

Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.

Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion.

Yulun Huang, Lin Qi, Mari Kogiso, Yuchen Du, Frank K Braun, Huiyuan Zhang, L Frank Huang, Sophie Xiao, Wan-Yee Teo, Holly Lindsay, Sibo Zhao, Patricia Baxter, Jack M F Su, Adekunle Adesina, Jianhua Yang, Sebastian Brabetz, Marcel Kool, Stefan M Pfister, Murali Chintagumpala, Laszlo Perlaky, Zhong Wang, Youxin Zhou, Tsz-Kwong Man, Xiao-Nan Li

Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies

Lin Qi, Holly Lindsay, Mari Kogiso, Yuchen Du, Frank K Braun, Huiyuan Zhang, Lei Guo, Sibo Zhao, Sarah G Injac, Patricia A Baxter, Jack Mf Su, Sophie Xiao, Stephen W Erickson, Eric J Earley, Beverly Teicher, Malcolm A Smith, Xiao-Nan Li

Maximizing the potential of aggressive mouse tumor models in preclinical drug testing.

M Tarek Elghetany, Jia-Min Ho, Lois Hew Shi-Qi, Sekar Karthik, Jack M F Su, Qi Lin, YuChen Du, Jianhe Shen, Wing-Yuk Chow, Ching C Lau, Adekunle Adesina, Angela Major, Anat Erdreich-Epstein, Kam-Man Hui, Xiao-Nan Li, Wan-Yee Teo